Research News

Pros and cons of drugs to prevent breast cancer

BMJ 2013; 346 doi: (Published 08 May 2013) Cite this as: BMJ 2013;346:f2891

Pooled analyses of individual participant data from nine randomised trials have confirmed that selective oestrogen receptor (ER) modulators help prevent breast cancer in healthy women. Together, tamoxifen, raloxifene, arzoxifene, and lasofoxifene reduced the cumulative incidence of breast cancer by an estimated 38% relative to …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to to receive unlimited access to all content on for 14 days.
Sign up for a free trial